Journal of Medical Oncology is a peer-reviewed medical Oncology journal dedicated towards cancer research. The journal focuses on experimental oncology, clinical oncology and cancer epidemiology and its prevention. Journal of Medical Oncology communicates the results of current clinical and experimental research in oncology, paying special focus on experimental therapeutics, immunotherapy and chemotherapy.
The journal includes topics like Oncology, Chemotherapy, Radiotherapy, Breast Cancer, ovarian cancer, Lung Cancer, Brain Cancer, Surgical Oncology, Radiation Oncology, Pediatric Oncology, Tumour Cells, Haematology, Bone Marrow Transplantation, Immunotherapy, Malignant tumours, Immunobiology, pathogenesis, and treatment of malignant tumours.
The Journal aims to publish the most reliable and complete source of information on discoveries and current developments in the form of research articles, review articles, case reports and short communication. All articles are peer reviewed and published under the guidance of our Editorial Board members.
The branch of medical science that deals with prevention, diagnosis and treatment of tumor and cancer is known as oncology. Oncology consists of three main divisions that include medical oncology, surgical oncology and radiation oncology. Cancer is the uncontrolled and abnormal growth of cells .The factors responsible for cancer includes tobacco, alcohol, obesity and age. Its symptoms depend on the site and type of the cancer such as breast cancer, lung cancer, ovary cancer, cervix cancer etc. Diagnosis and treatment of cancer depends upon the site and type of cancer. The treatment of cancer includes surgery, chemotherapy, radiation and targeted therapy.
Related Journals of Oncology
Journal of Clinical Oncology, Lancet Oncology, International Journal of Radiation Oncology Biology Physics, Annals of OncologyAnnals of Surgical Oncology, Gynecologic Oncology, Radiotherapy and Oncology
Chemotherapeutic agents or anti-cancer drugs are used as a part of a standardized regimen in a category of cancer treatment known as chemotherapy. It is the one of the major categories of medical discipline specifically devoted to pharmacotherapy for cancer that may be given with combination of drugs with a curative intent or to reduce symptoms. In chemotherapy the drugs are introduced into the blood stream and therefore they can address cancer at any anatomic location in the body this constitutes a systematic therapy. It is often used in conjunction with other modalities such as radiation therapy, surgery etc. Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated.
Related Journals of Chemotherapy
Cancer Science and Therapy, Carcinogenesis, Chemotherapy, Infection and Chemotherapy, Antimicrobial Chemotherapy, Chemotherapy Research
Radiation therapy uses ionizing radiation generally as a part of cancer treatment to kill or control malignant cells and normally deliver by a linear accelerator.it is synergistic with chemotherapy and has been used during and after chemotherapy in susceptible cancers. Radiotherapy is mostly applied to the cancerous tumor because of its ability to control cell growth. The use of ionizing radiation in radiotherapy works by damaging the DNA of cancerous tissue leading to cellular death. The damage is caused by one of two types of energy, photon or charged particle that may be direct or indirect ionization of the atoms which make up the DNA chain. The response of a cancer to radiation is described by its radio sensitivity. Highly radiosensitive cancer cells are rapidly killed by modest doses of radiation. These include leukemia’s, most lymphomas and germ cell tumors.
Related Journals Of Radiation therapy
Stereotactic Radiation Therapy, Nuclear Medicine and Radiation Therapy, Radiotherapy and Oncology, Radiotherapy in Practice, Radiation Oncology, Radiology & Radiation Therapy.
Breast cancer is a type of cancer that basically develops from the breast tissue. The symptoms of breast cancer includes change in breast shape, fluid coming from the nipple, a lump in the breast, etc. and sometimes there may be pain in the bones, swelling of lymph nodes, shortness of breath or yellow skin. The first symptom of breast cancer is basically a lump that feels different from rest of the breast tissue. Sometimes lumps in the armpits also indicate breast cancer. Rather than lump formation sometimes thickening, one breast becoming larger or lower, disposition of the nipple or becoming inverted also indicates towards the breast cancer. The diagnosis of the breast cancer can be done by microscopic analysis of sample or by the biopsy of the affected area of the breast. Mammography and physical examination of the breast are the most commonly used screening methods for breast cancer.
Related Journals of Breast cancer
Breast Cancer Stem Cell, Breast Cancer Screening, Breast Cancer Chemotherapy, Breast Cancer, Breast Cancer Reports.
Ovarian cancer basically forms in or on an ovary that result in abnormal cells which have the ability to invade or spread to other parts of the body such as lining of the abdomen, lymph nodes, lungs an liver. There will be no symptoms or only vague symptoms during this process but when the cancer progresses the symptoms becomes noticeable. The symptoms include bloating, pelvic pain, abdominal swelling and loss of appetite. Ovarian cancer are difficult to diagnose at early stage because most symptoms are nonspecific and thus of little use and also the symptoms may appear similar to irritable bowel syndrome. As the cancer spreads and advances to the later stage the diagnosis is done. The screening methods start with physical examination, a blood test for CA-125, transvaginal ultrasound etc. sometimes retrovaginal examination is also done to plan a surgery.
Related Journals of Ovarian cancer
Current Trends in Gynecologic Oncology, Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Journal of Ovarian Research.
The uncontrolled cell growth in the tissue of the lungs that leads to a malignant lung tumor is known as lung cancer or carcinoma. Mostly lung cancer occurs due to long term tobacco smoking but in some cases it causes due to the combination of genetic factors and sometimes due to the exposure towards radon gas, asbestos, second hand smoke or other forms of air pollution. Lung cancer is also initiated by the activation of the oncogenes and the inactivation of the tumor suppression genes that leads to the mutation in these genes which induces the development of cancer. Chest radiographs and computed tomography scans can visualize the lung cancer. The symptoms of lung cancer normally includes respiratory problems such as coughing, coughing up blood, shortness of breath and sometimes systemic symptoms such as weakness, fever, chest pain etc. the diagnosis of lung carcinoma is confirmed by biopsy which is usually performed by bronchoscopy or CT guidance.
Related Journals of Lung cancer
Journal of Lung Cancer Diagnosis & Treatment, Journal of Lung Diseases & Treatment, Lung Cancer: Targets and Therapy, Japanese Journal of Lung Cancer, Lung India, Lung, Heart and Lung: Journal of Acute and Critical Care.
Author(s): Thomas Helleday
recurrent ovarian cancer and today there are already three PARP inhibitors approved; olaparib, rucaparib and niraparib. PARP inhibitors selectively target cancers with mutation of BRCA1 or BRCA2 allel ... Read More
Author(s): Ifegwu Ibe*, Behdokht Nowroozizadeh, Xiaohui S Zhao, Wamda Goreal, Naveen Bhandarkar, Beverly Wang
Sinus histocytosis with massive lymphadenopathy, aka Rosai-Dorfman disease (RDD) is a rare, non-hereditary, histiocytic proliferative disorder, usually involving lymph nodes but occasionally occurring ... Read More
Author(s): Noyde Batista-Albuerne1, Lidia González-Méndez2, Idrian García-García2, Eduardo Fernández- Sánchez3, Robin García-Diegues1, Ana de la Torre-Santos4, Yenima Martín-Bauta4, Ivette Raíces-Cruz2, Carmen M Valenzuela-Silva2, Vilcy Reyes-Nicolás2, Yasser Perera-Negrín2, Josué de la Torre-Pupo5, Daniel F Alonso6, Roberto Gómez7, Boris E Acevedo-Castro2, Verena L Muzio-González2, Silvio E Perea-Rodríguez2* and Jorge L Soriano-García1
Background: CIGB-300 is an anti-CK2 peptide previously tested by intralesional injections. Here, we explored tolerability, drug accumulation ratio and clinical benefit of intravenous CIGB-300 in patie ... Read More
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : April 25, 2018